Paul Budhan

Paul Budhan MBA is an accomplished leader in the pharmaceutical industry with extensive experience in oncology and haematology. As the Head of Franchise - IO GI Oncology & HER2 Tumour Agnostic at AstraZeneca since February 2020, Paul has successfully driven commercial growth, achieving a 40% portfolio expansion across various tumor areas. Previously, Paul held several key positions at Bayer Pharmaceuticals, including Divisional CFO and Oncology Franchise Manager for prostate cancer, and contributed to significant financial and strategic planning initiatives. With an MBA from the University of Warwick and multiple degrees in accounting and finance, Paul is also a qualified member of the Chartered Institute of Management Accountants.